These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 11953863)

  • 1. Phosphorothioate oligonucleotides, suramin and heparin inhibit DNA-dependent protein kinase activity.
    Hosoi Y; Matsumoto Y; Tomita M; Enomoto A; Morita A; Sakai K; Umeda N; Zhao HJ; Nakagawa K; Ono T; Suzuki N
    Br J Cancer; 2002 Apr; 86(7):1143-9. PubMed ID: 11953863
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phosphorothioate oligonucleotides are inhibitors of human DNA polymerases and RNase H: implications for antisense technology.
    Gao WY; Han FS; Storm C; Egan W; Cheng YC
    Mol Pharmacol; 1992 Feb; 41(2):223-9. PubMed ID: 1371582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suramin sensitizing cells to ionizing radiation by inactivating DNA-dependent protein kinase.
    Hosoi Y; Matsumoto Y; Enomoto A; Morita A; Green J; Nakagawa K; Naruse K; Suzuki N
    Radiat Res; 2004 Sep; 162(3):308-14. PubMed ID: 15378840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of phosphorothioate modifications on the ability of GTn oligodeoxynucleotides to specifically recognize single-stranded DNA-binding proteins and to affect human cancer cellular growth.
    Morassutti C; Scaggiante B; Dapas B; Xodo L; Tell G; Quadrifoglio F
    Biochimie; 1999 Dec; 81(12):1115-22. PubMed ID: 10607406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oligodeoxynucleotides enhance lipopolysaccharide-stimulated synthesis of tumor necrosis factor: dependence on phosphorothioate modification and reversal by heparin.
    Hartmann G; Krug A; Waller-Fontaine K; Endres S
    Mol Med; 1996 Jul; 2(4):429-38. PubMed ID: 8827713
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of suramin-related and other clinically therapeutic polyanions on protein kinase C activity.
    Khaled Z; Rideout D; O'Driscoll KR; Petrylak D; Cacace A; Patel R; Chiang LC; Rotenberg S; Stein CA
    Clin Cancer Res; 1995 Jan; 1(1):113-22. PubMed ID: 9815893
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of suramin on p34cdc2 kinase in vitro and in extracts from human H69 cells: evidence for a double mechanism of action.
    Bojanowski K; Nishio K; Fukuda M; Larsen AK; Saijo N
    Biochem Biophys Res Commun; 1994 Sep; 203(3):1574-80. PubMed ID: 7945307
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple mechanisms may contribute to the cellular anti-adhesive effects of phosphorothioate oligodeoxynucleotides.
    Khaled Z; Benimetskaya L; Zeltser R; Khan T; Sharma HW; Narayanan R; Stein CA
    Nucleic Acids Res; 1996 Feb; 24(4):737-45. PubMed ID: 8604318
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of T4 polynucleotide kinase activity by phosphorothioate and chimeric oligodeoxynucleotides.
    Teasdale RM; Matson SJ; Fisher E; Krieg AM
    Antisense Res Dev; 1994; 4(4):295-7. PubMed ID: 7734945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of gene expression with double-stranded phosphorothioate oligonucleotides.
    Bielinska A; Shivdasani RA; Zhang LQ; Nabel GJ
    Science; 1990 Nov; 250(4983):997-1000. PubMed ID: 2237444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of herpes simplex virus type 2 growth by phosphorothioate oligodeoxynucleotides.
    Gao WY; Hanes RN; Vazquez-Padua MA; Stein CA; Cohen JS; Cheng YC
    Antimicrob Agents Chemother; 1990 May; 34(5):808-12. PubMed ID: 2163243
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phosphorothioate oligonucleotides inhibit the intrinsic tenase complex.
    Sheehan JP; Lan HC
    Blood; 1998 Sep; 92(5):1617-25. PubMed ID: 9716589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A targeted inhibition of DNA-dependent protein kinase sensitizes breast cancer cells following ionizing radiation.
    Kim CH; Park SJ; Lee SH
    J Pharmacol Exp Ther; 2002 Nov; 303(2):753-9. PubMed ID: 12388662
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of murine macrophage nitric oxide production by synthetic oligonucleotides.
    Zhu FG; Reich CF; Pisetsky DS
    J Leukoc Biol; 2002 Apr; 71(4):686-94. PubMed ID: 11927656
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Specific inhibition of influenza virus RNA polymerase and nucleoprotein genes expression by liposomally endocapsulated antisense phosphorothioate oligonucleotides: penetration and localization of oligonucleotides in clone 76 cells.
    Hatta T; Takai K; Nakada S; Yokota T; Takaku H
    Biochem Biophys Res Commun; 1997 Mar; 232(2):545-9. PubMed ID: 9125219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biochemical characterization of the HIV-1 integrase 3'-processing activity and its inhibition by phosphorothioate oligonucleotides.
    Tramontano E; Colla PL; Cheng YC
    Biochemistry; 1998 May; 37(20):7237-43. PubMed ID: 9585536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p53 interference and growth inhibition in p53-mutant and overexpressing endometrial cancer cell lines.
    Janicek MF; Angioli R; Unal AD; Sevin BU; Madrigal M; Estape R; Averette HE
    Gynecol Oncol; 1997 Jul; 66(1):94-102. PubMed ID: 9234928
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of human chymase by suramin.
    Takao K; Takai S; Ishihara T; Mita S; Miyazaki M
    Jpn J Pharmacol; 1999 Dec; 81(4):404-7. PubMed ID: 10669049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibitory effects of telomere-mimic phosphorothioate oligonucleotides on various human tumor cells in vitro.
    Ohnuma T; Li FL; Holland JF
    Anticancer Res; 1997; 17(4A):2455-8. PubMed ID: 9252662
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective inactivation of DNA-dependent protein kinase with antisense oligodeoxynucleotides: consequences for the rejoining of radiation-induced DNA double-strand breaks and radiosensitivity of human cancer cell lines.
    Sak A; Stuschke M; Wurm R; Schroeder G; Sinn B; Wolf G; Budach V
    Cancer Res; 2002 Nov; 62(22):6621-4. PubMed ID: 12438258
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.